Tag: Celltrion

Zymfentra (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab, was approved by the FDA in October 2023. Yes, **is Zymfentra available in the USA**, having become commercially available nationwide in March 2024.

With a wholesale acquisition cost (WAC) reported around $6,181 for a four-week supply, Zymfentra is a high-cost biologic medication used for inflammatory bowel disease. Understanding **how much does Zymfentra cost**, however, requires looking beyond this list price to consider factors like insurance coverage, discount cards, and patient assistance programs.